Optimind Pharma Corp.
Optimind Pharma Corp.
Share · CA68405U1012 (XCNQ)
Overview
No Price
n/a
Share Float & Liquidity
Free Float 96,71 %
Shares Float 99,76 M
Shares Outstanding 103,15 M
Company Profile for Optimind Pharma Corp. Share
Optimind Pharma Corp. operates as a pharmaceutical company in Canada. The company offers psychedelic therapies for treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It also operates a clinic that provides medical cannabis and other alternative treatments for various medical ailments, including ketamine-enhanced psychotherapy. The company is headquartered in Toronto, Canada.
Get up to date insights from finAgent about Optimind Pharma Corp.

Company Data

Name Optimind Pharma Corp.
Company Optimind Pharma Corp.
Website https://optimindpharma.com
Primary Exchange XCNQ CSE LISTED
ISIN CA68405U1012
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO David Goodman
Country Canada
Currency CAD
Employees -
Address TD Centre, North Tower, M5K 1G8 Toronto
IPO Date 2022-08-04

Ticker Symbols

Name Symbol
CSE LISTED OMND.CN
More Shares
Investors who hold Optimind Pharma Corp. also have the following shares in their portfolio:
INVESTEC BANK PLC IMPALA QUAD IDX 4 YR KO NTS 13/03/22
INVESTEC BANK PLC IMPALA QUAD IDX 4 YR KO NTS 13/03/22 Bond
XYLEM 20/28
XYLEM 20/28 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025